Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.170
-0.010 (-0.31%)
At close: Mar 6, 2026, 4:00 PM EST
3.155
-0.015 (-0.48%)
After-hours: Mar 6, 2026, 6:47 PM EST
Cabaletta Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 35.7 | 32.23 | 22.5 | 14.84 | 13.82 | 12.72 | |
| Research & Development | 127.72 | 92.91 | 52.17 | 39.3 | 32.49 | 21.11 | |
| Operating Expenses | 163.42 | 125.14 | 74.66 | 54.14 | 46.31 | 33.83 | |
| Operating Income | -163.42 | -125.14 | -74.66 | -54.14 | -46.31 | -33.83 | |
| Interest Expense | -2.2 | -0.75 | - | - | - | - | |
| Interest & Investment Income | 6.65 | 10.03 | 6.99 | 1.16 | 0.02 | 0.49 | |
| EBT Excluding Unusual Items | -158.52 | -115.86 | -67.68 | -52.98 | -46.29 | -33.34 | |
| Pretax Income | -158.52 | -115.86 | -67.68 | -52.98 | -46.29 | -33.34 | |
| Net Income | -158.52 | -115.86 | -67.68 | -52.98 | -46.29 | -33.34 | |
| Net Income to Common | -158.52 | -115.86 | -67.68 | -52.98 | -46.29 | -33.34 | |
| Shares Outstanding (Basic) | 66 | 49 | 41 | 29 | 26 | 23 | |
| Shares Outstanding (Diluted) | 66 | 49 | 41 | 29 | 26 | 23 | |
| Shares Change (YoY) | 36.24% | 19.77% | 39.54% | 14.01% | 11.20% | 323.18% | |
| EPS (Basic) | -2.41 | -2.36 | -1.65 | -1.81 | -1.80 | -1.44 | |
| EPS (Diluted) | -2.41 | -2.36 | -1.65 | -1.81 | -1.80 | -1.44 | |
| Free Cash Flow | -120.26 | -90.43 | -54.24 | -48.83 | -35.28 | -27.41 | |
| Free Cash Flow Per Share | -1.83 | -1.84 | -1.32 | -1.66 | -1.37 | -1.18 | |
| EBITDA | -161.65 | -123.43 | -73.23 | -52.96 | -45.58 | -33.48 | |
| D&A For EBITDA | 1.77 | 1.71 | 1.43 | 1.18 | 0.73 | 0.35 | |
| EBIT | -163.42 | -125.14 | -74.66 | -54.14 | -46.31 | -33.83 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.